Search - tctmd.com

Displaying 1 - 20 of 42

Sort: Relevancy | Date

News Opinion CV Team Dispatch

November 2024 Dispatch for the CV Team

L.A. McKeown

November 26, 2024

Presentation TCT 2024

TCT 583: Influence of Heparin-Induced Thrombocytopenia on In-Hospital Outcomes in Patients With Left Ventricular Assist Devices (LVAD): A Decade-Long Study

Presenter: Neethi Dasu

October 30, 2024

Presentation TCT 2024

TAVR for LVAD-Associated AR

Presenter: Ravi Ramana

October 30, 2024

Presentation TCT 2024

Debate Con: Early LVAD as a Bridge to Recovery

Presenter: Phyllis Billia

October 29, 2024

Presentation TCT 2024

TCT 1567: Radial Access for Bilateral Iliofemoral Disease in an LVAD Patient

Presenter: Mary Parro

October 29, 2024

Presentation TCT 2024

TCT 1117: Breaking New Ground by Breaking Thrombus: A Novel Approach to Acute Aortic Root Thrombus Following LVAD Implantation

Presenter: Ahmed Kazem

October 27, 2024

News Conference News EACTS 2024

Will Semaglutide Change Cardiac Surgery? It Already Has

Yael L. Maxwell

October 10, 2024

News Daily News

FDA Approves Dropping Aspirin for HeartMate 3 LVAD Patients

L.A. McKeown

August 21, 2024

News Daily News

Device Correction Issued for HeartMate Monitor Due to Potential Pump Stoppage

Todd Neale

June 28, 2024

Presentation NY Valves 2024

When and How to Treat LVAD Associated Severe AR

Presenter: Gabriel Sayer

June 05, 2024

News Daily News

HeartMate 3 Recalled for Risk of Blood Leaks or Air in System

L.A. McKeown

May 15, 2024

News Daily News

HeartMate II and 3 LVADs Recalled Due to Potential for Outflow Graft Obstruction

Caitlin E. Cox

April 22, 2024

News Daily News

In Transporting Donor Hearts, SherpaPak Shows Promise Over Traditional Coolers

Yael L. Maxwell

April 18, 2024

News Conference News ACC 2024

Interatrial Shunt Falls Short in Sham-Controlled RELIEVE-HF

Michael O'Riordan

April 06, 2024

News Conference News CRT 2024

SAFE-MCS: Monitoring System Intercepts Bleeding in High-risk PCI

L.A. McKeown

March 15, 2024

News Conference News THT 2024

Small Study Hints at Apixaban’s Potential in LVAD-Treated Patients

Michael O'Riordan

March 07, 2024

Presentation THT 2024

CRT/ICD in LVAD Patients

Presenter: Gabriel Sayer

March 05, 2024

Presentation THT 2024

Derivation and Validation of a Multicenter Model to Identify Candidates for Advanced HF Therapies with High Potential to Achieve post-LVAD Reverse Cardiac Remodeling

Presenter: Stavros G. Drakos

March 05, 2024

Presentation THT Abstracts 2024

Central and Peripheral Determinants of Exercise with the HeartMate 3TM LVAD

Presenter: David Golombeck

March 05, 2024

Presentation THT Abstracts 2024

Functional Outcomes Following Temporary Mechanical Circulatory Support Bridging to Left Ventricular Assist Device (LVAD)

Presenter: John Eisenga

March 05, 2024

Advertisement

November 2024 Dispatch for the CV Team

TCT 583: Influence of Heparin-Induced Thrombocytopenia on In-Hospital Outcomes in Patients With Left Ventricular Assist Devices (LVAD): A Decade-Long Study

TAVR for LVAD-Associated AR

Debate Con: Early LVAD as a Bridge to Recovery

TCT 1567: Radial Access for Bilateral Iliofemoral Disease in an LVAD Patient

TCT 1117: Breaking New Ground by Breaking Thrombus: A Novel Approach to Acute Aortic Root Thrombus Following LVAD Implantation

Will Semaglutide Change Cardiac Surgery? It Already Has

FDA Approves Dropping Aspirin for HeartMate 3 LVAD Patients

Device Correction Issued for HeartMate Monitor Due to Potential Pump Stoppage

When and How to Treat LVAD Associated Severe AR

HeartMate 3 Recalled for Risk of Blood Leaks or Air in System

HeartMate II and 3 LVADs Recalled Due to Potential for Outflow Graft Obstruction

In Transporting Donor Hearts, SherpaPak Shows Promise Over Traditional Coolers

Interatrial Shunt Falls Short in Sham-Controlled RELIEVE-HF

SAFE-MCS: Monitoring System Intercepts Bleeding in High-risk PCI

Small Study Hints at Apixaban’s Potential in LVAD-Treated Patients

CRT/ICD in LVAD Patients

Derivation and Validation of a Multicenter Model to Identify Candidates for Advanced HF Therapies with High Potential to Achieve post-LVAD Reverse Cardiac Remodeling

Central and Peripheral Determinants of Exercise with the HeartMate 3TM LVAD

Functional Outcomes Following Temporary Mechanical Circulatory Support Bridging to Left Ventricular Assist Device (LVAD)

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content